ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced positive results from the preliminary analysis of its second and final Bepreve(TM) (bepotastine ophthalmic solution) Phase III clinical study. The ...
The Institute of Science and Technology Austria (ISTA) in Klosterneuburg and Google have signed a “Master Sponsored Research Agreement” to explore joint scientific research areas. Under this agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results